Background: Longitudinal magnetic resonance imaging (MRI) studies show that a fraction of the multiple sclerosis (MS) T2-lesions contain T1-hypointense components that may persist to represent severe, irreversible tissue damage. It is not known why certain lesions convert to persistent T1-hypointense lesions.
Objective: We hypothesized that the T1-hypointense lesions disproportionately distribute in the more hypoperfused areas of the brain. Here we investigated the association between hypoperfusion and T1-hypointense lesion distributions.
Methods: MRI and cerebral blood flow (CBF) data were acquired on 45 multiple sclerosis (MS) patients and 20 healthy controls. CBF maps were generated using pseudo-continuous arterial spin labeling technique. The lesion probability distribution maps were superimposed on the CBF maps.
Results: Two distinct CBF clusters were observed in the white matter (WM) both in healthy controls and MS patients. An overall reduction in CBF was observed in MS patients compared to healthy controls. The majority of the T1-hypointense lesions were concentrated almost exclusively in the WM regions with lower CBF. The T2-hyperintense lesions were more generally distributed in both higher and lower perfused WM.
Conclusion: This study suggests an association between hypoperfusion and T1-hypointense lesions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844029 | PMC |
http://dx.doi.org/10.1177/1352458513495936 | DOI Listing |
Vet Radiol Ultrasound
January 2025
Department of Surgical Sciences, The University of Wisconsin, School of Veterinary Medicine, Madison, Wisconsin, USA.
A 10-year-old female spayed boxer was treated with stereotactic radiotherapy (SRT) for a suspected glioma in the left piriform lobe. The intra-axial lesion was T2 hyperintense, T2 FLAIR hyperintense, T1 hypointense, and did not uptake contrast. Imaging was performed with an MRI every 3 months, and at the 6-month recheck, new lesions in the left hippocampus and right piriform lobe were evident without clinically apparent neurological progression.
View Article and Find Full Text PDFRadiol Case Rep
December 2024
Department of Radiology, Queen Mary Hospital, Hong Kong, People's Republic of China.
Mult Scler Relat Disord
October 2024
Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:
Background: Multiple sclerosis (MS) is a prevalent, disabling, inflammatory, neurodegenerative disease that typically manifests during a highly productive stage of life. Interferon beta-1a was among the first approved disease-modifying therapies for MS and remains among the first-line treatment options. Pegylation of the interferon beta-1a molecule prolongs its half-life while maintaining its efficacy and safety profile.
View Article and Find Full Text PDFJ Breast Imaging
May 2024
Department of Pathology, Stanford Medicine, Stanford, CA, USA.
Breast hemangiomas are rare benign vascular lesions. In a previously performed review of approximately 10,000 breast surgical pathology results, roughly 0.15% (15/~10 000) were hemangiomas.
View Article and Find Full Text PDFAJNR Am J Neuroradiol
April 2024
Mayo Clinic (P.A., P.M., I.T.M., S.A.M., G.B.), Rochester, Minnesota.
High-grade astrocytoma with piloid features (HGAP) is a recently identified brain tumor characterized by a distinct DNA methylation profile. Predominantly located in the posterior fossa of adults, HGAP is notably prevalent in individuals with neurofibromatosis type 1. We present an image-centric review of HGAP and explore the association between HGAP and neurofibromatosis type 1.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!